Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China · Delayed Price · Currency is CNY 32.13
-1.03 (-3.11%)
Jan 23, 2026, 3:04 PM CST
SHE:300878 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -315.38 | -147.43 | -8.95 | 48.81 | 96.5 | 135.82 | Upgrade |
Depreciation & Amortization | 67.52 | 67.52 | 46.65 | 42.38 | 26.99 | 12.17 | Upgrade |
Other Amortization | 2.14 | 2.14 | 2.36 | 2.62 | 3.06 | 3.74 | Upgrade |
Loss (Gain) From Sale of Assets | 0.47 | 0.47 | 0.01 | 0.63 | -0.07 | 0 | Upgrade |
Asset Writedown & Restructuring Costs | 84.03 | 84.03 | -3.9 | 0.4 | 0.11 | 0.01 | Upgrade |
Loss (Gain) From Sale of Investments | -91.12 | -91.12 | -12.6 | -14.79 | -0.26 | - | Upgrade |
Provision & Write-off of Bad Debts | 3.18 | 3.18 | -11.46 | 7.31 | 8.41 | 8.11 | Upgrade |
Other Operating Activities | 264.34 | 18.18 | 11.9 | 6.08 | 2.21 | 0.37 | Upgrade |
Change in Accounts Receivable | 72.92 | 72.92 | 63.42 | 38.67 | -151.67 | -122.43 | Upgrade |
Change in Inventory | -7.15 | -7.15 | -37.6 | -3.03 | -45.62 | -21.85 | Upgrade |
Change in Accounts Payable | -8.54 | -8.54 | 24.55 | 8.74 | 10.16 | 26.2 | Upgrade |
Operating Cash Flow | 51.04 | -27.17 | 58.29 | 145.18 | -67.74 | 42.81 | Upgrade |
Operating Cash Flow Growth | - | - | -59.85% | - | - | -62.03% | Upgrade |
Capital Expenditures | -58.8 | -126.92 | -139.29 | -173.39 | -171.1 | -152.34 | Upgrade |
Sale of Property, Plant & Equipment | 0.17 | 4.51 | 0.02 | 0.32 | 0.23 | 0.03 | Upgrade |
Cash Acquisitions | - | - | - | -9.79 | -32.27 | - | Upgrade |
Divestitures | 31.24 | 37.32 | - | - | 13.69 | - | Upgrade |
Investment in Securities | - | 241 | -240.57 | -5.16 | -2.91 | -19.96 | Upgrade |
Other Investing Activities | -17.59 | 6.76 | 240.01 | -254.41 | - | - | Upgrade |
Investing Cash Flow | -19.35 | 188.29 | 9.31 | -442.43 | -192.35 | -172.27 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 30 | Upgrade |
Long-Term Debt Issued | - | 189.01 | 377.04 | 288.81 | 50 | - | Upgrade |
Total Debt Issued | 18.75 | 189.01 | 377.04 | 288.81 | 50 | 30 | Upgrade |
Short-Term Debt Repaid | - | - | - | -0.5 | - | -181.18 | Upgrade |
Long-Term Debt Repaid | - | -326.71 | -275 | -64.02 | -28.65 | - | Upgrade |
Total Debt Repaid | -89.97 | -326.71 | -275 | -64.52 | -28.65 | -181.18 | Upgrade |
Net Debt Issued (Repaid) | -71.22 | -137.69 | 102.04 | 224.28 | 21.35 | -151.18 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 762.43 | Upgrade |
Repurchase of Common Stock | -50 | -50 | - | - | - | - | Upgrade |
Common Dividends Paid | -28.18 | -44.4 | -7.02 | -45.74 | -80.99 | -7.83 | Upgrade |
Other Financing Activities | 57.2 | -2 | 2.55 | 0.2 | 5.68 | -34.53 | Upgrade |
Financing Cash Flow | -92.2 | -234.09 | 97.57 | 178.74 | -53.96 | 568.89 | Upgrade |
Net Cash Flow | -60.51 | -72.97 | 165.17 | -118.51 | -314.06 | 439.43 | Upgrade |
Free Cash Flow | -7.77 | -154.1 | -81 | -28.21 | -238.84 | -109.53 | Upgrade |
Free Cash Flow Margin | -5.90% | -43.88% | -15.59% | -5.30% | -37.73% | -17.59% | Upgrade |
Free Cash Flow Per Share | -0.05 | -1.08 | -0.54 | -0.20 | -1.66 | -0.91 | Upgrade |
Cash Income Tax Paid | 4.37 | 30.67 | 34.29 | 27.98 | 69.23 | 49.87 | Upgrade |
Levered Free Cash Flow | 131.62 | -84.38 | 316 | -405.82 | -304.93 | -145.36 | Upgrade |
Unlevered Free Cash Flow | 138.37 | -78.54 | 321.9 | -402.44 | -303.58 | -145.2 | Upgrade |
Change in Working Capital | 35.85 | 35.85 | 34.29 | 51.73 | -204.69 | -117.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.